CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M ALBUMIN AGGREGATED KIT
✉ Email this page to a colleague
All Clinical Trials for technetium tc-99m albumin aggregated kit
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02773238 ↗ | FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging | Recruiting | National Cancer Institute (NCI) | Phase 2 | 2016-05-01 | This phase II trial studies how well positron emission tomography (PET)/computed tomography (CT) and single positron emission computed tomography (SPECT)/CT imaging works in improving radiation therapy treatment in patients with stage IIB-IIIB non-small cell lung cancer. PET/CT imaging mid-way through treatment may be able to accurately show how well radiation therapy and chemotherapy are working. SPECT/CT imaging may be able to tell which parts of the lung tissue are healthier than others. Based on the result of the imaging, treatment adjustments may be made to the radiation therapy to improve survival and decrease toxicity. |
NCT02773238 ↗ | FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging | Recruiting | University of Washington | Phase 2 | 2016-05-01 | This phase II trial studies how well positron emission tomography (PET)/computed tomography (CT) and single positron emission computed tomography (SPECT)/CT imaging works in improving radiation therapy treatment in patients with stage IIB-IIIB non-small cell lung cancer. PET/CT imaging mid-way through treatment may be able to accurately show how well radiation therapy and chemotherapy are working. SPECT/CT imaging may be able to tell which parts of the lung tissue are healthier than others. Based on the result of the imaging, treatment adjustments may be made to the radiation therapy to improve survival and decrease toxicity. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for technetium tc-99m albumin aggregated kit
Condition Name
Condition Name for technetium tc-99m albumin aggregated kit | |
Intervention | Trials |
Stage IIB Non-Small Cell Lung Carcinoma | 1 |
Stage IIIA Non-Small Cell Lung Cancer | 1 |
Stage IIIB Non-Small Cell Lung Cancer | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for technetium tc-99m albumin aggregated kit
Trials by Country
Clinical Trial Progress for technetium tc-99m albumin aggregated kit
Clinical Trial Phase
Clinical Trial Sponsors for technetium tc-99m albumin aggregated kit
Sponsor Name